Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

February 01, 2014; Volume 348,Issue 2

Highlighted Papers

  • You have access
    Aryl Hydrocarbon Receptor Antagonism Attenuates Growth Factor Expression in Rheumatoid Arthritis
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 216; DOI: https://doi.org/10.1124/jpet.114.0214HI
  • You have access
    Glycemic and Vascular Dysfunction in Caveolin-1 Null Mice
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 216; DOI: https://doi.org/10.1124/jpet.114.0214HIa
  • You have access
    Phosphoinositide 3-Kinase-δ,γ Inhibitor for Rheumatoid Arthritis
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 216; DOI: https://doi.org/10.1124/jpet.114.0214HIb
  • You have access
    Modulating Heat Shock Protein 70 Improves Diabetic Neuropathy
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 216; DOI: https://doi.org/10.1124/jpet.114.0214HIc

Behavioral Pharmacology

  • You have access
    A Double Blind, within Subject Comparison of Spontaneous Opioid Withdrawal from Buprenorphine versus Morphine
    D. Andrew Tompkins, Michael T. Smith, Miriam Z. Mintzer, Claudia M. Campbell and Eric C. Strain
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 217-226; DOI: https://doi.org/10.1124/jpet.113.209478
  • You have access
    Antinociceptive Effects of Central Administration of the Endogenous Cannabinoid Receptor Type 1 Agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-Terminally Extended Hemopressin Peptide
    Zheng-lan Han, Quan Fang, Zi-long Wang, Xu-hui Li, Ning Li, Xue-mei Chang, Jia-xin Pan, Hong-zhu Tang and Rui Wang
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 316-323; DOI: https://doi.org/10.1124/jpet.113.209866

Cardiovascular

  • You have access
    Dissociation of Hyperglycemia from Altered Vascular Contraction and Relaxation Mechanisms in Caveolin-1 Null Mice
    Luminita H. Pojoga, Tham M. Yao, Lauren A. Opsasnick, Amanda E. Garza, Ossama M. Reslan, Gail K. Adler, Gordon H. Williams and Raouf A. Khalil
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 260-270; DOI: https://doi.org/10.1124/jpet.113.209189

Cellular and Molecular

  • You have access
    Aryl Hydrocarbon Receptor Antagonism Attenuates Growth Factor Expression, Proliferation, and Migration in Fibroblast-Like Synoviocytes from Patients with Rheumatoid Arthritis
    Tejas S. Lahoti, Jarod M. Hughes, Ann Kusnadi, Kaarthik John, Bokai Zhu, Iain A. Murray, Krishne Gowda, Jeffrey M. Peters, Shantu G. Amin and Gary H. Perdew
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 236-245; DOI: https://doi.org/10.1124/jpet.113.209726
  • You have access
    Regulation of Death Induction and Chemosensitizing Action of 3-Bromopyruvate in Myeloid Leukemia Cells: Energy Depletion, Oxidative Stress, and Protein Kinase Activity Modulation
    Eva Calviño, María Cristina Estañ, Carlos Sánchez-Martín, Rocío Brea, Elena de Blas, María del Carmen Boyano-Adánez, Eduardo Rial and Patricio Aller
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 324-335; DOI: https://doi.org/10.1124/jpet.113.206714
  • You have access
    Mechanism of hERG Channel Block by the Psychoactive Indole Alkaloid Ibogaine
    Patrick Thurner, Anna Stary-Weinzinger, Hend Gafar, Vaibhavkumar S. Gawali, Oliver Kudlacek, Juergen Zezula, Karlheinz Hilber, Stefan Boehm, Walter Sandtner and Xaver Koenig
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 346-358; DOI: https://doi.org/10.1124/jpet.113.209643

Chemotherapy, Antibiotics, and Gene Therapy

  • You have access
    Combined Antiproliferative Effects of the Aminoalkylindole WIN55,212-2 and Radiation in Breast Cancer Cells
    Sean M. Emery, Moureq R. Alotaibi, Qing Tao, Dana E. Selley, Aron H. Lichtman and David A. Gewirtz
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 293-302; DOI: https://doi.org/10.1124/jpet.113.205120

Drug Discovery and Translational Medicine

  • You have access
    Heat Shock Protein 70 Is Necessary to Improve Mitochondrial Bioenergetics and Reverse Diabetic Sensory Neuropathy following KU-32 Therapy
    Jiacheng Ma, Kevin L. Farmer, Pan Pan, Michael J. Urban, Huiping Zhao, Brian S. J. Blagg and Rick T. Dobrowsky
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 281-292; DOI: https://doi.org/10.1124/jpet.113.210435

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • You have access
    Mucosal Protective Agents Prevent Exacerbation of NSAID-Induced Small Intestinal Lesions Caused by Antisecretory Drugs in Rats
    Hiroshi Satoh, Kikuko Amagase and Koji Takeuchi
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 227-235; DOI: https://doi.org/10.1124/jpet.113.208991

Inflammation, Immunopharmacology, and Asthma

  • You have access
    Novel Phosphoinositide 3-Kinase δ,γ Inhibitor: Potent Anti-Inflammatory Effects and Joint Protection in Models of Rheumatoid Arthritis
    David L. Boyle, Hae-Rim Kim, Katharyn Topolewski, Beatrix Bartok and Gary S. Firestein
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 271-280; DOI: https://doi.org/10.1124/jpet.113.205955
  • You have access
    Bronchoprotection by Olodaterol Is Synergistically Enhanced by Tiotropium in a Guinea Pig Model of Allergic Asthma
    Marieke Smit, Annet B. Zuidhof, Sophie I. T. Bos, Harm Maarsingh, Reinoud Gosens, Johan Zaagsma and Herman Meurs
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 303-310; DOI: https://doi.org/10.1124/jpet.113.208439

Metabolism, Transport, and Pharmacogenomics

  • You have access
    Absence of P-Glycoprotein Transport in the Pharmacokinetics and Toxicity of the Herbicide Paraquat
    Sarah E. Lacher, Julia N. Gremaud, Kasse Skagen, Emily Steed, Rachel Dalton, Kent D. Sugden, Fernando Cardozo-Pelaez, Catherine M. T. Sherwin and Erica L. Woodahl
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 336-345; DOI: https://doi.org/10.1124/jpet.113.209791

Neuropharmacology

  • You have access
    Inhibition of Excitatory Synaptic Transmission in Hippocampal Neurons by Levetiracetam Involves Zn2+-Dependent GABA Type A Receptor–Mediated Presynaptic Modulation
    Masahito Wakita, Naoki Kotani, Kyuya Kogure and Norio Akaike
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 246-259; DOI: https://doi.org/10.1124/jpet.113.208751
  • You have access
    RETRACTION: Maintained Cocaine Self-Administration Is Determined by Quantal Responses: Implications for the Measurement of Antagonist Potency
    Andrew B. Norman, Michael R. Tabet, Mantana K. Norman and Vladimir L. Tsibulsky
    Journal of Pharmacology and Experimental Therapeutics February 2014, 348 (2) 311-315; DOI: https://doi.org/10.1124/jpet.113.210690
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 348 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 348, Issue 2
1 Feb 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Highlighted Papers
  • Behavioral Pharmacology
  • Cardiovascular
  • Cellular and Molecular
  • Chemotherapy, Antibiotics, and Gene Therapy
  • Drug Discovery and Translational Medicine
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics